This content is machine translated Dementia Research Synergistic effects of ginkgo biloba extract and donepezil The efficacy of Ginkgo biloba extract and donepezil in promoting cognitive performance has been empirically demonstrated. Individual studies also support the hypothesis that an additional benefit can be achieved through…
View Post 4 min This content is machine translated CGRP antibodies for migraine prophylaxis Reduce the hammering in the head CGRP* antibodies for the prevention of migraine attacks, which have been approved since 2018, offer affected patients the possibility of a reduction in their headache days. Erenumab was the first…
View Post 10 min This content is machine translated Pharmacological pain therapy Place of opioids in the treatment of chronic pain Opioids form a pharmacologically heterogeneous group of synthetic, semisynthetic, and natural agents whose common feature is binding to opioid receptors. With regard to the development of analgesic effects, the opioid… CME-Test
View Post 3 min This content is machine translated Spinal muscular atrophy Clinical experience speaks for individual therapy management Spinal muscular atrophy is a rare genetic disorder characterized by the loss of motor neurons in the spinal cord and lower brainstem. In the meantime, experts agree that therapy management must…
View Post 2 min This content is machine translated Parkinson's disease Updates in the management of Parkinson’s syndrome Shaking hands, stiff muscles, unsteady gait – the typical signs of Parkinson’s disease. Up to now only symptomatically treatable, intensive research is being conducted to find an individual therapeutic approach.…
View Post 3 min This content is machine translated Primary headache Problem case migraine: pharmacotherapy put to the test There are many types of headaches. Migraine is certainly one of the most common. Even more so, a form that carries a high burden and far-reaching effects on the quality…
View Post 3 min This content is machine translated Multiple sclerosis Effective treatment strategies right from the start – opportunities, risks, benefits Treatment of multiple sclerosis is aimed at reducing relapses, lowering disease activity, and slowing the progression of the disease and increase in disability. Both course and long-term therapy with e.g.…
View Post 12 min This content is machine translated Immune-mediated neuropathies The role of autoantibodies in polyneuropathies. Immune-mediated neuropathies vary in clinical presentation, course, and pathogenesis. In recent years, autoantibodies against nodal and paranodal proteins of the Ranvier lacing ring have been detected. The autoantibodies can cause… CME-Test
View Post 13 min This content is machine translated Multiple sclerosis New therapeutic option supports first-line management of RRMS Treatment of MS, the autoimmune disease of the central nervous system that most often leads to disability in young adulthood, has made many small advances over the past two decades,… CME-Test
View Post 5 min This content is machine translated Advanced Parkinson's disease Effective use of pump therapy A 64-year-old Parkinson’s disease patient developed massive effect fluctuations and severe worsening of symptoms under conventional therapy. Only the use of a continuous intrajejunal dopaminergic stimulation by pump therapy led to…
View Post 4 min This content is machine translated Pregnancy and multiple sclerosis Family planning with MS therapy need not be a challenge Multiple sclerosis (MS) predominantly affects women between the ages of 20 and 45 at the time of diagnosis – with an increasing incidence [1,2]. As a result, not only is…
